Clinical Study
Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases
Table 6
The relationships between plasma asprosin level and metabolic and sex hormone profiles of PCOS females and the subgroups categorized by BMI.
| | PCOS | PCOS (age-adjusted) | PCOS normal-weight(age-adjusted) | PCOS overweight/obese (age-adjusted) | | | | | | | | |
| Age (years) | −0.118 | 0.463 | — | — | — | — | — | — | BMI (kg/m2) | 0.201 | 0.207 | 0.150 | 0.365 | 0.276 | 0.411 | −0.164 | 0.403 | WHR | −0.087 | 0.590 | 0.083 | 0.609 | −0.090 | 0.793 | 0.014 | 0.946 | FBG (mmol/L) | 0.148 | 0.355 | 0.636 | 0.000 | −0.019 | 0.956 | 0.692 | <0.001 | FINS (mU/mL) | 0.328 | 0.036 | 0.179 | 0.269 | −0.079 | 0.818 | 0.090 | 0.649 | OGTT-30 min insulin (mU/mL) | 0.188 | 0.357 | 0.169 | 0.419 | 0.664 | 0.150 | −0.016 | 0.949 | EHCT-0 min-insulin (mU/mL) | 0.699 | 0.002 | 0.456 | 0.076 | 0.541 | 0.636 | 0.365 | 0.244 | EHCT-90 min-insulin (mU/mL) | 0.429 | 0.086 | 0.311 | 0.240 | −0.822 | 0.385 | 0.249 | 0.435 | EHCT-180 min-insulin (mU/mL) | 0.544 | 0.024 | 0.396 | 0.129 | −0.344 | 0.776 | 0.385 | 0.216 | HOMA-IR | 0.429 | 0.005 | 0.544 | 0.000 | −0.109 | 0.749 | 0.563 | 0.002 | HOMA-β | −0.054 | 0.773 | −0.026 | 0.875 | −0.064 | 0.880 | −0.229 | 0.319 | HbA1c (%) | 0.630 | 0.000 | 0.645 | 0.000 | 0.593 | 0.092 | 0.602 | 0.001 | TG (mmol/L) | 0.250 | 0.135 | 0.206 | 0.229 | −0.315 | 0.447 | 0.233 | 0.242 | TC (mmol/L) | 0.226 | 0.178 | 0.389 | 0.019 | 0.322 | 0.422 | 0.327 | 0.096 | LDL-c (mmol/L) | 0.400 | 0.019 | 0.466 | 0.006 | 0.331 | 0.424 | 0.421 | 0.041 | HDL-c (mmol/L) | −0.284 | 0.093 | 0.163 | 0.349 | 0.354 | 0.390 | 0.149 | 0.466 | APOE (mg/dL) | 0.310 | 0.070 | 0.503 | 0.002 | 0.521 | 0.150 | 0.464 | 0.022 | APOB (g/L) | 0.411 | 0.013 | 0.439 | 0.008 | 0.086 | 0.827 | 0.400 | 0.047 | APOA1 (g/L) | −0.279 | 0.100 | 0.062 | 0.722 | −0.317 | 0.406 | 0.078 | 0.711 | T (nmol/L) | 0.294 | 0.062 | 0.340 | 0.027 | −0.118 | 0.729 | 0.379 | 0.047 | FSH (mIU/L) | 0.153 | 0.340 | 0.092 | 0.573 | 0.504 | 0.114 | 0.119 | 0.547 | LH (mIU/L) | 0.068 | 0.674 | 0.022 | 0.892 | 0.348 | 0.295 | 0.031 | 0.977 | LH/FSH | −0.080 | 0.621 | −0.063 | 0.698 | −0.091 | 0.790 | −0.077 | 0.697 | E2 (pg/mL) | −0.091 | 0.570 | −0.132 | 0.419 | 0.669 | 0.024 | −0.304 | 0.116 | P (ng/mL) | −0.195 | 0.221 | −0.232 | 0.150 | −0.271 | 0.420 | −0.331 | 0.085 | PRL (ng/mL) | −0.414 | 0.007 | −0.39 | 0.013 | −0.293 | 0.382 | −0.464 | 0.013 | SHBG (nmol/L) | −0.429 | 0.016 | −0.247 | 0.188 | −0.924 | 0.003 | −0.115 | 0.610 | DHEA-S (μg/dl) | 0.042 | 0.833 | 0.166 | 0.407 | 0.836 | 0.078 | 0.379 | 0.090 | 17α-OHP (ng/mL) | 0.044 | 0.853 | 0.011 | 0.966 | 0.855 | 0.145 | 0.018 | 0.952 | AMH (ng/mL) | −0.202 | 0.407 | −0.201 | 0.423 | −0.938 | 0.062 | −0.085 | 0,783 | WBC (109/L) | 0.112 | 0.504 | 0.102 | 0.546 | 0.050 | 0.899 | 0.026 | 0.897 | CRP (mg/L) | −0.009 | 0.958 | −0.002 | 0.989 | 0.209 | 0.619 | 0.124 | 0.547 | TNF-α (pg/mL) | 0.236 | 0.266 | 0.107 | 0.628 | 0.962 | 0.176 | 0.003 | 0.989 | IL-6 (pg/mL) | 0.449∗ | 0.028 | 0.229 | 0.293 | −0.474 | 0.686 | 0.174 | 0.477 | IL-8 (pg/mL) | 0.342 | 0.120 | 0.124 | 0.592 | −0.447 | 0.705 | 0.052 | 0.481 |
|
|
Note: Correlations between variables were analyzed by Spearman’s correlation test and an age-adjusted partial correlation test. EHCT: euglycemic-hyperinsulinemic clamp test; SHBG: sex hormone-binding globulin; DHEA-S: dehydroepiandrosterone sulfate; 17α-OHP: 17-α-hydroxyprogesterone; AMH: anti-Mullerian hormone; TNF-α: tumor necrosis factor-α; IL-6: interleukin-6.
|